SCOPUS 정보 검색 플랫폼

Biology of Blood and Marrow Transplantation

Volumn 7, Issue 8, 2001, Pages 439-445

Randomized open-label trial of dolasetron for the control of nausea and vomiting associated with high-dose chemotherapy with hematopoietic stem cell transplantation

(4) Bubalo, Joseph a Seelig, Florence a Karbowicz, Sean a Maziarz, Richard T a

a OREGON HEALTH AND SCIENCE UNIVERSITY (United States)

Author keywords

Bone marrow transplantation; Chemotherapy; Dolasetron; Emesis; Granisetron; Hematopoietic stem cell transplantation; Nausea; Ondansetron; Total body irradiation; Vomiting

Indexed keywords

ANTIEMETIC AGENT; ANTINEOPLASTIC AGENT; BUSULFAN; CARBOPLATIN; CARMUSTINE; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DEXAMETHASONE; DOLASETRON MESILATE; ETOPOSIDE; GRANISETRON; LORAZEPAM; MELPHALAN; ONDANSETRON; THIOTEPA;

ADULT; ADVERSE DRUG REACTION; APPETITE; ARTICLE; CANCER; CANCER RADIOTHERAPY; CLINICAL TRIAL; CONDITIONING; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG MEGADOSE; DRUG RESPONSE; DRUG SAFETY; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; MAJOR CLINICAL STUDY; MALE; NAUSEA AND VOMITING; PARAMETER; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SCORING SYSTEM; STANDARD; TASTE; UNIVERSITY HOSPITAL; WHOLE BODY RADIATION;

EID: 0034796398 PISSN: 10838791 EISSN: None Source Type: Journal
DOI: 10.1016/S1083-8791(01)80011-2 Document Type: Article

Times cited : (18)

References (18)

1
- 85031480350
- Anzemet injection, dolasetron mesylate injection prescribing information [package insert]. Kansas City, Mo: Hoechst Marion Roussel
- (1999)

2
- 85031483305
- Zofran, ondansetron hydrochloride prescribing information [package insert]. Research Triangle Park, NC: GlaxoWellcome
- (1999)

3
- 85031485929
- Kytril, granisetron hydrochloride injection prescribing information [package insert]. Philadelphia, Pa: SmithKline Beecham Pharmaceuticals
- (1998)

4
- 85031487586
- Kytril, granisetron hydrochloride tablets prescribing information [package insert]. Philadelphia, Pa: SmithKline Beecham Pharmaceuticals
- (1999)

5
- 85031486001
- Anzemet tablets, dolasetron mesylate prescribing information [package insert]. Kansas City, Mo: Hoechst Marion Roussel
- (1997)

6
- 0032847992
- Recommendations for the use of antiemetics: Evidence-based, clinical practice guidelines
- American Society of Clinical Oncology [published correction appears in J Clin Oncol. 1999;17:3860]
- (1999) J Clin Oncol. , vol.17 , pp. 2971-2994
- Gralla, R.J.¹ Osoba, D.² Kris, M.G.³

7
- 85031486904
- CancerNet (PDQ) [database online]. Nausea and Vomiting Supportive Care-Health Professionals. Bethesda, Md: National Cancer Institute; 2001. Updated April 25
- (2001)

8
- 0032526721
- Outcomes of antiemetic therapy after the administration of high-dose antineoplastic agents
- (1998) Am J Health Syst Pharm. , vol.55 , pp. 1269-1274
- Trovato, J.A.¹ Stull, D.M.² Finley, R.S.³

9
- 85031487210
- Prospective evaluation of antiemetic outcome following high-dose chemotherapy with hematopoietic stem cell support
- [abstract] May 20-23, New Orleans, LA. Baltimore, Md: Lippincott, Williams, and Wilkins; 2000:606a. Abstract 2387.
- (2000) Proceedings of the 36th Annual Meeting of the American Society of Clinical Oncology , vol.19
- Hesketh, P.J.¹ Ballen, K.² Hesketh, A.M.³

10
- 7844241232
- An open-label dose comparison study of ondansetron for the prevention of emesis associated with chemotherapy prior to bone marrow transplantation
- (1998) Support Care Cancer. , vol.6 , pp. 511-517
- Osowski, C.L.¹ Dix, S.P.² Lynn, M.³

11
- 9444264707
- Double-blind, randomized comparison of the antiemetic efficacy of intravenous dolasetron mesylate and intravenous ondansetron in the prevention of acute cisplatin-induced emesis in patients with cancer
- Dolasetron Comparative Chemotherapy-induced Emesis Prevention Group.
- (1996) J Clin Oncol. , vol.14 , pp. 2242-2249
- Hesketh, P.¹ Navari, R.² Grote, T.³

12
- 8944260906
- A double-blind, randomised comparison of the anti-emetic efficacy of two intravenous doses of dolasetron mesylate and granisetron in patients receiving high dose cisplatin chemotherapy
- (1996) Eur J Cancer. , vol.32 A , pp. 807-813
- Audhuy, B.¹ Cappelaere, P.² Martin, M.³

13
- 0032606998
- A prospective randomized trial of the anti-emetic efficacy of ondansetron and granisetron during bone marrow transplantation
- (1999) Biol Blood Marrow Transplant. , vol.5 , pp. 386-393
- Orchard, P.J.¹ Rogosheske, J.² Burns, L.³

14
- 0031594743
- 5-HT3 receptor antagonists for the prevention of chemotherapy-induced nausea and vomiting: A comparison of their pharmacology and clinical efficacy
- (1998) Drugs. , vol.55 , pp. 173-189
- Gregory, R.E.¹ Ettinger, D.S.²

15
- 9344231964
- Granisetron in the prevention of vomiting induced by conditioning for stem cell transplantation: A prospective randomized study
- (1996) Bone Marrow Transplant. , vol.17 , pp. 679-683
- Okamoto, S.¹ Takahashi, S.² Tanosaki, R.³

16
- 0034067385
- Efficacy and safety of oral granisetron versus i.v. granisetron in patients undergoing peripheral blood progenitor cell and bone marrow transplantation
- (2000) Anticancer Drugs. , vol.11 , pp. 137-142
- Abang, A.M.¹ Takemoto, M.H.² Pham, T.³

17
- 0030800690
- An all oral antiemetic regimen for patients undergoing high-dose chemotherapy with peripheral blood stem cell transplant
- (1997) Bone Marrow Transplant. , vol.20 , pp. 473-478
- Frakes, L.A.¹ Brehm, T.L.² Kosty, M.P.³

18
- 0033561077
- ASHP therapeutic guidelines on the pharmacologic management of nausea and vomiting in adult and pediatric patients receiving chemotherapy or radiation therapy or undergoing surgery
- (1999) Am J Health Syst Pharm. , vol.56 , pp. 729-764

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.